Skip to main content
. Author manuscript; available in PMC: 2013 Jul 29.
Published in final edited form as: JAMA Intern Med. 2013 Jun 10;173(11):1006–1012. doi: 10.1001/jamainternmed.2013.639

Figure 2.

Figure 2

Percent of nonmelanoma skin cancers treated with Mohs, excision, destruction, other, or no treatment. LLE indicates limited life expectancy.